In this current study, five tumor-infiltrating immune cell types were more prevalent in the high ARMCX1 expression group, while five other tumor-infiltrating immune cells (Naïve B cells, resting CD4 memory T cells, monocytes, M2 macrophages, and resting mast cells), which were prevalent in the low ARMCX1 expression group. This evidence concerns the gene CD4 and neoplasm.